P

PerkinElmer Inc
LSE:0KHE

Watchlist Manager
PerkinElmer Inc
LSE:0KHE
Watchlist
Price: 101.0659 USD 3.65% Market Closed
Market Cap: 1.1T USD

PerkinElmer Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

PerkinElmer Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
P
PerkinElmer Inc
LSE:0KHE
Research & Development
-$206.9m
CAGR 3-Years
12%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
Thermo Fisher Scientific Inc
NYSE:TMO
Research & Development
-$1.4B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Danaher Corp
NYSE:DHR
Research & Development
-$1.6B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Mettler-Toledo International Inc
NYSE:MTD
Research & Development
-$196.8m
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
Agilent Technologies Inc
NYSE:A
Research & Development
-$455m
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
-3%
IQVIA Holdings Inc
NYSE:IQV
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

PerkinElmer Inc
Glance View

PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.

0KHE Intrinsic Value
1.7805 USD
Overvaluation 98%
Intrinsic Value
Price
P

See Also

What is PerkinElmer Inc's Research & Development?
Research & Development
-206.9m USD

Based on the financial report for Sep 28, 2025, PerkinElmer Inc's Research & Development amounts to -206.9m USD.

What is PerkinElmer Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-5%

Over the last year, the Research & Development growth was -5%. The average annual Research & Development growth rates for PerkinElmer Inc have been 12% over the past three years , -1% over the past five years , and -5% over the past ten years .

Back to Top